Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Synergic Effects of Bitter Melon and ${\beta}$-Glucan Composition on STZ-Induced Rat Diabetes and Its Complications

  • Kim, Joo-Wan (Glucan Corp. Research Institute, Marine Biotechnology Center) ;
  • Cho, Hyung-Rae (Glucan Corp. Research Institute, Marine Biotechnology Center) ;
  • Moon, Seung-Bae (Glucan Corp. Research Institute, Marine Biotechnology Center) ;
  • Kim, Ki-Young (Glucan Corp. Research Institute, Marine Biotechnology Center) ;
  • Ku, Sae-Kwang (Department of Anatomy and Histology, College of Oriental Medicine, Daegu Haany University)
  • Received : 2011.06.17
  • Accepted : 2011.09.26
  • Published : 2012.01.28
Download PDF
⟨ Previous Next ⟩

Abstract

${\beta}$-Glucan purified from oats (OG) and bitter melon, Momordica charantia Linn (MC), water extracts have shown favorable effects on diabetes and its complications. We investigated to find out the optimal composition showing hypoglycemic and antidiabetic complication effects in variable compositions (OG:MC = 1:1, 1:2, 1:4, 1:6, 1:8, 1:10, 2:1, 4:1, 6:1, 8:1, 10:1). Extracts were administered orally once a day for 28 days following 7 days post streptozotocin (STZ) dosing. Five rats per group (total 15 groups; Intact, STZ, OG, MC, and the variable composition groups) were selected according to the blood glucose and body weight at 6 days after STZ dosing. After 28 days of extracts dosing, the changes on the body weight, liver and kidney weight, blood glucose, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST) and alanine aminotransferase (ALT), low-density lipoprotein (LDL), and total-cholesterol levels were observed. As the result of STZ-induced diabetes, decreases of body weight, increases of the liver and kidney weights, blood glucose, BUN, creatinine, AST, ALT, LDL, and total-cholesterol levels in STZ control were detected compared with intact control. However, these changes of hyperglycemia, diabetic nephropathy, hepatopathy, and hyperlipemia were dramatically decreased in the OG and MC single-dosing group, and all composition groups. In addition, there were more favorable effects in all composition groups compared with the OG and MC single-dosing groups. Among variable compositions, the OG:MC 1:2 mixed group showed the most synergic effects in this study.

Keywords

References

  1. Ahmed, I., E. Adeghate, E. Cummings, A. K. Sharma, and J. Singh. 2004. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocininduced diabetes mellitus in rat. Mol. Cell. Biochem. 261: 63-70. https://doi.org/10.1023/B:MCBI.0000028738.95518.90
  2. Anjaneyulu, M. and K. Chopra. 2005. Diltiazem attenuates oxidative stress in diabetic rats. Ren. Fail. 27: 335-344. https://doi.org/10.1081/JDI-56630
  3. Bell, S., V. M. Goldman, B. R. Bistrian, A. H. Arnold, G. Ostroff, and R. A. Forse. 1999. Effect of beta-glucan from oats and yeast on serum lipids. Crit. Rev. Food Sci. Nutr. 39: 189-202. https://doi.org/10.1080/10408399908500493
  4. Bhandari, U., R. Kanojia, and K. K. Pillai. 2005. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J. Ethnopharmacol. 97: 227-230. https://doi.org/10.1016/j.jep.2004.11.011
  5. Bourdon, I., W. Yokoyama, P. Davis, C. Hudson, R. Backus, D. Richter, et al. 1999. Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. Am. J. Clin. Nutr. 69: 55-63. https://doi.org/10.1093/ajcn/69.1.55
  6. Ceriello, A., A. Quatraro, and D. Giugliano. 1992. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet. Med. 9: 297-299. https://doi.org/10.1111/j.1464-5491.1992.tb01783.x
  7. Chen, Q., L. L. Chan, and E. T. Li. 2003. Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J. Nutr. 133: 1088-1093. https://doi.org/10.1093/jn/133.4.1088
  8. Clark, T. A., C. E. Heyliger, A. L. Edel, D. P. Goel, and G. N. Pierce. 2004. Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in streptozotocininduced diabetic rats. Metabolism 53: 1145-1151. https://doi.org/10.1016/j.metabol.2004.03.017
  9. Coskun, O., A. Ocakci, T. Bayraktaroglu, and M. Kanter. 2004. Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku J. Exp. Med. 203: 145-154. https://doi.org/10.1620/tjem.203.145
  10. De Paula, A. C., R. V. Sousa, R. C. Figueiredo-Ribeiro, and M. S. Buckeridge. 2005. Hypoglycemic activity of polysaccharide fractions containing beta-glucans from extracts of Rhynchelytrum repens (Willd.) C. E. Hubb., Poaceae. Braz. J. Med. Biol. Res. 38: 885-893. https://doi.org/10.1590/S0100-879X2005000600010
  11. Ducobu, J. 2005. Dyslipidaemia and diabetes mellitus. Rev. Med. Liege 60: 578-585.
  12. Estrada, A., C. H. Yun, A. Van Kessel, B. Li, S. Hauta, and B. Laarveld. 1997. Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbiol. Immunol. 41: 991-998. https://doi.org/10.1111/j.1348-0421.1997.tb01959.x
  13. Gonzalez, E., J. Rosello-Catafau, A. Jawerbaum, D. Sinner, C. Pustovrh, J. Vela, et al. 2000. Pancreatic nitric oxide and oxygen free radicals in the early stages of streptozotocininduced diabetes mellitus in the rat. Braz. J. Med. Biol. Res. 33: 1335-1342. https://doi.org/10.1590/S0100-879X2000001100012
  14. Grover, J. K. and S. P. Yadav. 2004. Pharmacological actions and potential uses of Momordica charantia: A review. J. Ethnopharmacol. 93: 123-132. https://doi.org/10.1016/j.jep.2004.03.035
  15. Grover, J. K., V. Vats, S. S. Rathi, and R. Dawar. 2001. Traditional Indian anti-diabetic plants attenuate progression of renal damage in streptozotocin-induced diabetic mice. J. Ethnopharmacol. 76: 233-238. https://doi.org/10.1016/S0378-8741(01)00246-X
  16. Guerrero-Analco, J. A., P. Hersch-Martinez, J. Pedraza-Chaverri, A. Navarrete, and R. Mata. 2005. Antihyperglycemic effect of constituents from Hintonia standleyana in streptozotocininduced diabetic rats. Planta Med. 71: 1099-1105. https://doi.org/10.1055/s-2005-873137
  17. Inzucchi, S. E. 2002. Oral antihyperglycemic therapy for type 2 diabetes: Scientific review. JAMA 287: 360-372. https://doi.org/10.1001/jama.287.3.360
  18. Kamata, K. and T. Kobayashi. 1996. Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br. J. Pharmacol. 119: 583-589. https://doi.org/10.1111/j.1476-5381.1996.tb15712.x
  19. Krizkova, L., Z. Durackova, J. Sandula, D. Slamenova, V. Sasinkova, M. Sivonova, and J. Krajcovic. 2003. Fungal beta- (1-3)-D-glucan derivatives exhibit high antioxidative and antimutagenic activity in vitro. Anticancer Res. 23: 2751-2756.
  20. Maiti, R., U. K. Das, and D. Ghosh. 2005. Attenuation of hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats by aqueous extract of seed of Tamarindus indica. Biol. Pharm. Bull. 28: 1172-1176. https://doi.org/10.1248/bpb.28.1172
  21. Milionis, H. J., A. I. Kakafika, S. G. Tsouli, V. G. Athyros, E. T. Bairaktari, K. I. Seferiadis, and M. S. Elisaf. 2004. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am. Heart J. 148: 635-640. https://doi.org/10.1016/j.ahj.2004.04.005
  22. Miura, T., Y. Itoh, N. Iwamoto, M. Kato, and T. Ishida. 2004. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice. Biol. Pharm. Bull. 27: 248-250. https://doi.org/10.1248/bpb.27.248
  23. Pick, M. E., Z. J. Hawrysh, M. I. Gee, E. Toth, M. L. Garg, and R. T. Hardin. 1996. Oat bran concentrate bread products improve long-term control of diabetes: A pilot study. J. Am. Diet. Assoc. 96: 1254-1261. https://doi.org/10.1016/S0002-8223(96)00329-X
  24. Quine, S. D. and P. S. Raghu. 2005. Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in streptozotocininduced diabetic liver, kidney and heart. Pharmacol. Rep. 57: 610-615.
  25. Rathi, S. S., J. K. Grover, and V. Vats. 2002. The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother. Res. 16: 236-243. https://doi.org/10.1002/ptr.842
  26. Rathi, S. S., J. K. Grover, V. Vikrant, and N. R. Biswas. 2002. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytother. Res. 16: 774-777. https://doi.org/10.1002/ptr.1064
  27. Sarkar, S., M. Pranava, and R. Marita. 1996. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol. Res. 33: 1-4. https://doi.org/10.1006/phrs.1996.0001
  28. Sathishsekar, D. and S. Subramanian. 2005. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats. Biol. Pharm. Bull. 28: 978-983. https://doi.org/10.1248/bpb.28.978
  29. Sener, G., H. Toklu, F. Ercan, and G. Erkanli. 2005. Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int. Immunopharmacol. 5: 1387-1396. https://doi.org/10.1016/j.intimp.2005.03.007
  30. Seufert, J., G. Lubben, K. Dietrich, and P. C. Bates. 2004. A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus. Clin. Ther. 26: 805-818. https://doi.org/10.1016/S0149-2918(04)90125-7
  31. Sodikoff, C. H. 1995. Laboratory Profiles of Small Animal Diseases. A Guide to Laboratory Diagnosis, pp. 1-36. 2nd Ed. Mosby, St. Louise.
  32. Trachtman, H., S. Futterweit, E. Pine, J. Mann, and E. Valderrama. 2002. Chronic diabetic nephropathy: Role of inducible nitric oxide synthase. Pediatr. Nephrol. 17: 20-29. https://doi.org/10.1007/s004670200004
  33. Tunali, S. and R. Yanardag. 2006. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats. Pharmacol. Res. 53: 271-277. https://doi.org/10.1016/j.phrs.2005.12.004
  34. Welihinda, J., E. H. Karunanayake, M. H. Sheriff, and K. S. Jayasinghe. 1986. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J. Ethnopharmacol. 17: 277-282. https://doi.org/10.1016/0378-8741(86)90116-9
  35. Wilson, T. A., R. J. Nicolosi, B. Delaney, K. Chadwell, V. Moolchandani, T. Kotyla, et al. 2004. Reduced and high molecular weight barley beta-glucans decrease plasma total and non-HDL-cholesterol in hypercholesterolemic Syrian golden hamsters. J. Nutr. 134: 2617-2622. https://doi.org/10.1093/jn/134.10.2617
  36. Wolff, S. P. 1993. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br. Med. Bull. 49: 642-652. https://doi.org/10.1093/oxfordjournals.bmb.a072637

Cited by

  1. 당뇨 유발 흰쥐에서 삼채뿌리 첨가 식이가 혈당과 지질 수준에 미치는 영향 vol.26, pp.6, 2012, https://doi.org/10.17495/easdl.2016.12.26.6.481